Masthead
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Editorial Board
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Table of Contents
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Hemodialysis Catheter Device Protection: Damned if We Do; Patients Are Damned if We Don't
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): Daniel L. Landry, Gregory L. Braden, Jerry Yee (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

The Many Faces of Infection in CKD: Evolving Paradigms, Insights, and Novel Therapies
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): Mohanram Narayanan (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Immune Dysfunction and Risk of Infection in Chronic Kidney Disease
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): Maaz Syed-Ahmed, Mohanram NarayananCardiovascular disease and infections are directly or indirectly associated with an altered immune response, which leads to a high incidence of morbidity and mortality, and together, they account for up to 70% of all deaths among patients with chronic kidney dysfunction. Impairment of the normal reaction of the innate and adaptive immune systems in chronic kidney disease predisposes patients to an increased risk of infections, virus-associated cancers, and a diminished vaccine response. ...
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Current Concepts in Hemodialysis Vascular Access Infections
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): Lalathaksha Kumbar, Jerry YeeInfection-related causes are second only to cardiovascular events for mortality among end-stage renal disease patients. This review will provide an overview of hemodialysis catheter-, graft-, and fistula-related infections with emphasis on diagnosis and management in specific settings. Use of catheters at the initiation of dialysis has remained unchanged at 80%. Of all access-related bloodstream infections (BSIs), 70% occur in patients with catheters. The risk factors for BSIs in tunneled, cuf...
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Peritoneal Dialysis Access Associated Infections
This article reviews current knowledge with regards to prevention of PD-associated infections, and the diagnosis and management of exit site infections and peritonitis. (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): Mayur S. Ramesh, Jerry YeeClostridioides difficile infection (CDI) is a major health-care burden and increasingly seen in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Increased antibiotic use, alteration in host defenses, and gastric acid suppression are some of the etiologies for increased risk of CDI in these populations. Patients with CKD/ESRD have a higher risk of initial episode, recurrence, and development of severe CDI than those without CKD or ESRD. Diagnosis and management of CDI...
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Mycobacterial Infections in Patients With Chronic Kidney Disease and Kidney Transplantation
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): Lizbeth J. Cahuayme-Zuniga, Karen B. BrustPatients with chronic kidney disease have impaired immunity that increases their risk of infection. Increased incidence of mycobacterial infections, in particular Mycobacterium tuberculosis, is described in patients undergoing hemodialysis and peritoneal dialysis as well as after kidney transplantation in low-prevalence and high-prevalence settings. Diagnosis of this infection can be challenging because of atypical presentations that may lead to treatment delay and, consequently, ...
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Pathophysiology and Treatment of Hepatitis B and C Infections in Patients With End-Stage Renal Disease
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): Vivek Soi, Chantale Daifi, Jerry Yee, Elizabeth AdamsAn in-depth understanding of viral hepatitis is important to the care of patients with end-stage renal disease undergoing hemodialysis. Both hepatitis B and C viruses are acquired through hematogenous spread and can lead to horizontal transmission. Concurrent hepatic and renal injuries have ominous outcomes with significant morbidity. Hepatitis B incidence has decreased through practices including vaccination of nonimmune individuals and isolation of patients with the d...
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Prevention and Treatment of Multidrug-Resistant Organisms in End-Stage Renal Disease
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): John K. Midturi, Sangeetha RanganathChronic kidney disease patients are at high risk for infections because of multidrug-resistant organisms. Infections are the second most common cause of death in patients with ESRD. Patients with ESRD are prone to infections given alterations in immunity, increased rates of colonization with multidrug-resistant organisms, increased hospitalizations, and interactions with health care systems. Infections range from urinary tract infections, pneumonia, skin and soft tissue infections, cent...
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Antibiotic Dosing in Chronic Kidney Disease and End-Stage Renal Disease: A Focus on Contemporary Challenges
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): A. Mary VilayInfections are an important cause of morbidity and mortality among patients with chronic kidney disease. Therefore, appropriate antibiotic dosing is imperative to achieve positive patient outcomes while minimizing antibiotic dose-related toxicity. Accurately assessing renal function and determining the influence of renal replacement therapy on antibiotic clearance makes drug dosing in this patient population challenging. Furthermore, as technological advances in hemodialysis and peritoneal dialysis occur, res...
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Vaccination in Chronic Kidney Disease
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): Snigdha Reddy, Chandrika Chitturi, Jerry YeeInfections after cardiovascular disease are the second most common cause of death in the chronic kidney disease population. Vaccination is an important component of maintaining health and wellness in patients with kidney disease. There is a changing epidemiologic landscape for several vaccine-preventable illnesses from childhood to adulthood and unfounded public perception of safety concerns. Several mechanisms have been proposed to cause inadequate vaccine protection in this hi...
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Erratum to “Leadership as Tribal Leader”
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

NKF 2019 Spring Clinical Meetings Physician Program
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

NKF 2019 Spring Clinical Meetings Nephrology Nurse Program
Publication date: January 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 1Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - March 13, 2019 Category: Urology & Nephrology Source Type: research

Masthead
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Editorial Board
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Table of Contents
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Leadership as Tribal Leader
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): Jerry Yee (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Leadership in Nephrology: Vital to the Future of Our Profession
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): Rebecca J. Schmidt (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

A History of Leadership in Dialysis: Perspectives From Seasoned Leaders
This article includes Nephrology Oral History Project excerpts illustrating leadership contributions to dialysis machines, peritoneal dialysis catheters, and treatment best practices. In addition to individual contributions, improvements in treatment also come from patient and provider organizations leading the way and collectively advocating for change. Nephrology leaders continue to play a crucial role in improving dialysis outcomes and quality of life. (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Leadership as a Division Chief of Nephrology
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): Eleanor LedererThe position of chief of a division of nephrology in an academic medical center is a hands-on job, offering the opportunity to influence the future of the field through the creation of unique clinical, research, and education programs. Today, most academic centers face significant financial challenges, thus the division chief must develop a variety of skills to accomplish his or her goals. Interactions and relationships with the leadership of the academic center, including the hospital executives, can faci...
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Leading a Dialysis Organization: Role and Responsibilities of the Chief Medical Officer (Nephrologist Leadership in a Dialysis Provider Organization)
This article reviews the roles, responsibilities, and opportunities of the position as established in a midsize nonprofit dialysis provider. (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Administrative Leadership: Nephrologists in Non-nephrology Leadership Roles
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): Michael Gitman, Alessandro Bellucci, Steven FishbaneNephrologists, perhaps more than other physicians, are drawn to health-care leadership positions. In this article, we consider reasons that nephrologists are uniquely suited to serve in these roles. We briefly review key aspects of leadership principles and skills. Finally, we discuss routes to non-nephrology leadership for younger members of the profession. (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Leadership in a Private Nephrology Practice: Autonomy Is More Than a Dream!
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): Nelson Kopyt, Ravindra BolluPrivate practice is entering an era of diminishing reimbursement and increasing overhead associated with federally mandated payment reforms resulting in a need to move from the traditional fee-for-service to a value-based model, changes that place financial and organizational strain on nephrology practices. In addition, the changing geopolitical scene is one of mergers and consolidation of health care networks, which in turn are developing their own insurance plans or partnering with commercia...
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Leading the Dialysis Unit: Role of the Medical Director
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): Sharmeela Saha, Jay B. WishThe responsibilities of a dialysis unit medical director are specified in the ESRD Conditions for Coverage and encompass multiple quality, safety, and educational domains. Many of these responsibilities require leadership skills that are neither intuitive nor acquired as part of the medical director's training. An effective medical director is able to shape the culture of the dialysis facility such that patients and staff feel free to communicate their concerns regarding suboptimal processes wi...
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Nephrologist Leadership in Advocacy and Public Policy
This article explores the impact of nephrology leadership on government decision making and the important role of the nephrologist in advocacy and public policy at the Federal, state, and regional levels. (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Mentorship in Medicine and Nephrology: More Important Than Ever
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): Belinda Jim, Jerry YeeMentorship has always been important in medicine. In fact, one can argue that that is how doctors are trained. Moreover, mentorship has been proven to preserve and elevate those who wish to pursue academic medicine. In nephrology, mentorship has become paramount, as interest in the field has declined during this decade. In this article, we will delineate how mentorship impacts physician careers, describe different types of mentors and their characteristics, and summarize responsibilities of mentors ...
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Women in Nephrology Leadership
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): Wendy Weinstock Brown, Sharon AndersonWomen and men tend to take different paths to leadership, with men being more intentional. When women do undertake leadership activities, they tend to be surprised by how much they enjoy it. Women's leadership styles tend to be more collaborative and inclusive. Women are used to multitasking and tend to persist under difficult circumstances. The nephrology manpower crisis affects both men and women, although some of the drivers are different. There is a persistent and well-known pay ...
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Leading Integrated Kidney Care Entities of the Future
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): Douglas S. Johnson, Klemens B. MeyerThe leaders of 20th century kidney failure treatment took chances; 21st century leaders of integrated kidney care must do the same. Some risks are clinical, some are organizational, and some are financial. Decent and constructive leadership entails humility. A working practitioner is a better leader. Effective leaders empower their employees and collaborators to lead and encourage them to work together. Integrated kidney care leadership supports exchange of ideas within and among organ...
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Leadership in the Industry Arena: Nephrologists in Nonclinical Leadership Roles
Publication date: November 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 6Author(s): Akhtar AshfaqOf late, fewer residents are choosing nephrology as a career. Contributing factors may include lack of prestige, uncertain potential of future income, and poor work-life balance. Some current nephrologists are considering transitioning to another career for similar reasons. For those who decide that practicing nephrology is no longer appealing, there are many available avenues where they can use their nephrology expertise and still have a successful future. A leadership role in the pharmaceutical industry is...
Source: Advances in Chronic Kidney Disease - December 9, 2018 Category: Urology & Nephrology Source Type: research

Masthead
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Editorial Board
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Table of Contents
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

A Tale of Two Failures: A Guide to Shared Decision-Making for Heart and Renal Failure
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Hesham Shaban, Jerry Yee (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Cardiorenal Syndrome: A Call to Action for a Pressing Medical Issue
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Peter A. McCullough, Sandeep Soman (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Cardiorenal Syndrome: An Overview
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Claudio Ronco, Antonio Bellasi, Luca Di LulloIt is well established that a large number of patients with acute decompensated heart failure present with various degrees of heart and kidney dysfunction usually primary disease of heart or kidney often involve dysfunction or injury to the other. The term cardiorenal syndrome increasingly had been used without a consistent or well-accepted definition. To include the vast array of interrelated derangements and to stress the bidirectional nature of heart-kidney interactions, a...
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Epidemiology of Cardiorenal Syndrome
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Junior UdumanCardiorenal syndrome is a spectrum of disorders that emphasizes the bidirectional nature of cardiac and kidney injury. Observational and retrospective studies have helped us to understand the prevalence and burden of each of the 5 types of cardiorenal syndromes. Cardiorenal syndrome type 1 is the most common. The nature of epidemiologic data limits clear delineation between cardiorenal syndrome types 2 and 4. Overall, the presence of cardiac or renal dysfunction strongly predicts a poor outcome of the contr...
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Pathophysiological Mechanisms in Cardiorenal Syndrome
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Janani Rangaswami, Roy O. MathewCardiorenal syndrome represents the confluence of intricate hemodynamic, neurohormonal, and inflammatory pathways that initiate and propagate the maladaptive cross talk between the heart and kidneys. Several of these pathophysiological principles were described in older historical experiments. The last decade has witnessed major efforts in streamlining its definition, clinical phenotypes, and classification to improve diagnostic accuracy and deliver optimal goal-directed medical therapies...
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Heart–Kidney Interactions in Cardiorenal Syndrome Type 1
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Alberto Palazzuoli, Gaetano RuoccoThe exact significance of kidney function deterioration during acute decompensated heart failure (ADHF) episodes is still under debate. Several studies reported a wide percentage of worsening renal function (WRF) in ADHF patients ranging from 20% to 40%. This is probably because of different populations enrolled with different baseline kidney and cardiac function, varying definition of acute kidney injury (AKI), etiology of kidney dysfunction (KD), and occurrence of transient or permane...
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Toward Precision Medicine in the Cardiorenal Syndrome
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Nicholas Wettersten, Alan S. Maisel, Dinna N. CruzAlthough the field of oncology has made significant steps toward individualized precision medicine, cardiology and nephrology still often use a “one size fits all” approach. This applies to the intersection of the heart-kidney interaction and the cardiorenal syndrome as well. Recent studies have shown that the prognostic implications of worsening renal function (WRF) in acute heart failure are variable; thus, there is a need to differentiate the implications ...
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Diuretics in the Management of Cardiorenal Syndrome
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Chandrika Chitturi, James E. NovakThe leading cause of death worldwide is cardiovascular disease. The heart and the kidneys are functionally interdependent, such that dysfunction in one organ may cause dysfunction in the other. By one estimate, more than 60% of patients with congestive heart failure develop chronic kidney disease. Volume overload and congestion are hallmarks of heart failure, and these findings are associated with severe symptoms and poor outcomes. Given the importance of congestion, diuretics remain a ...
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Extracorporeal Isolated Ultrafiltration for Management of Congestion in Heart Failure and Cardiorenal Syndrome
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Amir Kazory, Maria Rosa CostanzoAcute decompensated heart failure has the highest rate of hospital readmission among all medical conditions and portends a significant financial burden on health care system. Congestion, the hallmark of acute decompensated heart failure, represents the primary reason for hospitalization and the driver of adverse outcomes in these patients. Although diuretic-based medical regimens remain the mainstay of management of acute decompensated heart failure, they often show suboptimal efficacy an...
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Advanced Heart Failure Therapies and Cardiorenal Syndrome
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Jennifer A. Cowger, Ryhm RadjefHeart failure (HF) is extremely prevalent and for those with end-stage (stage D) disease, 1-year survival is only 25-50%. Several studies have captured the mortality impact of kidney disease on patients with HF, and measures of kidney function are a component of many HF risk stratification scores. The management of advanced HF complicated by cardiorenal syndrome (CRS) is challenging, and irreversible kidney failure often limits patient candidacy for advanced HF therapies, such as transplan...
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4
Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Daniel Edmonston, Jessica D. Morris, John P. MiddletonChronic diseases of the heart and of the kidneys commonly coexist in individuals. Certainly combined and persistent heart and kidney failure can arise from a common pathologic insult, for example, as a consequence of poorly controlled hypertension or of severe diffuse arterial disease. However, strong evidence is emerging to suggest that cross talk exists between the heart and the kidney. Independent processes are set in motion when kidney function is chronically dim...
Source: Advances in Chronic Kidney Disease - October 9, 2018 Category: Urology & Nephrology Source Type: research

Masthead
Publication date: July 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 4Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - August 21, 2018 Category: Urology & Nephrology Source Type: research

Editorial Board
Publication date: July 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 4Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - August 21, 2018 Category: Urology & Nephrology Source Type: research

Table of Contents
Publication date: July 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 4Author(s): (Source: Advances in Chronic Kidney Disease)
Source: Advances in Chronic Kidney Disease - August 21, 2018 Category: Urology & Nephrology Source Type: research